In contrast, KMT2A rearrangements were associated with the loss of markers, including CD10 (Pro-B ALL phenotype), and were negatively associated with CD66c, CD73, and CD304 positivity. This evidence concerns the gene CEACAM6 and acute lymphoblastic leukemia.